The differences in insulin concentrations and estimated insulin resistance and beta cell function between these population groups were modestly reduced by adjustment for adiposity markers (by approximately 30%); adjustment for adiposity had little impact on differences in other risk markers. This evidence concerns the gene INS and Insulin resistance.